The Success of Acinetobacter Species; Genetic, Metabolic and Virulence AttributesAnton Y. Peleg, Lenie Dijkshoorn, Anna de Breij et al.|PLoS ONE|2012Cited by 189
Task force on management and prevention of Acinetobacter baumannii infections in the ICUJosé Garnacho‐Montero, Matteo Bassetti, George Dimοpoulos et al.|Intensive Care Medicine|2015Cited by 174
A global view on carbapenem-resistant <i>Acinetobacter baumannii</i>Carina Müller, Harald Seifert, Sandra Reuter et al.|mBio|2023Cited by 155
Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> BacteremiaThomas L Holland, Vance G. Fowler, Sara E. Cosgrove et al.|New England Journal of Medicine|2023Cited by 98
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definitionPatrick N. A. Harris, David L. Paterson, Anton Y. Peleg et al.|Clinical Microbiology and Infection|2016Cited by 83